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Detecting genetically engineered bacteria <p>New computational tools were used to find a robust set of DNA oligomers that can distinguish artificial vector sequences from all avail- able background viral and bacterial genomes.</p>
Abstract
Using newly designed computational tools we show that, despite substantial shared sequences
between natural plasmids and artificial vector sequences, a robust set of DNA oligomers can be
identified that can differentiate artificial vector sequences from all available background viral and
bacterial genomes and natural plasmids. We predict that these tools can achieve very high
sensitivity and specificity rates for detecting new unsequenced vectors in microarray-based
bioassays. Such DNA signatures could be important in detecting genetically engineered bacteria in
environmental samples.
Background
Synthetic vector sequences are of fundamental importance in
molecular biology. Cloning and expression vectors are among
a multitude of synthetic sequence types commonly used as
part of a basic tool set for DNA amplification and protein pro-
duction [1]. As the emerging maturity of synthetic biology
research fast approaches [2], it is reasonable to imagine in the
not too distant future the broad-scale manufacture of sophis-
ticated synthetic plasmids to modify existing bacteria and
possibly the construction of new functioning synthetic
genomes [3]. The potential exists to address challenges in
many areas, from food production [4] to drug discovery [5].
However, along with the potential benefit comes the
increased risk of engineered pathogens [6,7]. Thus, with
improvements in genetic manipulation comes the need for
tools to detect genetically modified bacteria in the
environment.
Large-scale computational pipelines have advanced bio-
defense by efficiently finding polymerase chain reaction
(PCR) assay-based primers that are able to accurately identify
dangerous bacterial and viral pathogens [8-10]. The develop-
ment of random DNA amplification methods have high-
lighted microarrays as a potentially practical multiplexing
complement to PCR [11] with DNA signatures on microarrays
[12]. Recent progress has made DNA signature design tools
widely available to pathogen research through the develop-
ment of a publicly available computational pipeline for
designing PCR-based signatures [13]. These advances dem-
onstrate the utility of DNA signature pipelines, but the ques-
tion remains whether such an approach could be used to
detect genetically engineered bacteria.
A computational analysis was performed on the available syn-
thetic vector sequences, which form an important basis for
current tools in genetic engineering [14]. One of the results of
this work is a report on the presence of DNA signatures found
to differentiate the vector sequences from the sequenced nat-
urally occurring plasmid and chromosomal DNA. Candidate
DNA signatures were found to cover nearly all artificial vector
sequences using a wide range of signature lengths. The pres-
ence of these candidate DNA signatures opens the potential to
develop assays in the future for detecting simple but widely
available forms of genetic engineering. The vector sequence
data was further leveraged to predict natural plasmids, which
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may form the basis for future vectors based on conserved
functional sequences.
Results and discussion
Vector DNA signatures
A total of 3,799 partial and complete artificial vector
sequences totaling 21,132,057 nucleotides were collected
from various sequence databases (details given in Materials
and methods) and analyzed for conserved sequence elements.
Sequences were compared using exact k-mer matching (a k-
mer is a nucleic acid sequence of length k). This alignment-
free comparative sequence approach [15,16] contrasts with
methods that use conserved order among compared
sequences [17]. The alignment-free comparison is motivated
by the abundance of similar artificial vector sequences, which
can differ in the relative order of functional elements owing to
differing sources of sequence construction. Conserved order
comparison is further confounded by transposable elements
and the need to efficiently compare several thousand
sequences simultaneously.
A k-mer found in the vector sequence but not in the natural
plasmid or chromosomal DNA is a candidate signature. The
length of k was varied to examine the change in candidate sig-
nature set size; the results are shown in Figure 1 (red line with
circles). There is a large jump in the percentage of k-mers that
are candidate signatures going from 15 to 18 with a continued
gradual increase as k increases above 18. The other lines in
Figure 1 show the percentage of vector k-mers shared exclu-
sively with the natural plasmid sequence (blue triangles) and
chromosome sequence (green triangles). More vector derived
15-mers are shared with the chromosome sequence (62%)
than with the natural plasmid sequence (1%) which is not sur-
prising since there are over 4 billion bases of background viral
and microbial sequence and less than 66 million bases of
sequenced natural plasmids. Nevertheless, the gap narrows
considerably at k = 18 with the chromosomal sequence show-
ing a much smaller percentage of k-mer matches, suggesting
that many of the matches under 18 are a result of random
chance.
k-mer sets collapse the redundant candidate signatures. A k-
mer set X for sequences from a set of input sequenced vectors
Y is the set of k-mers shared by all n sequences where n is
maximal. (There can be no additional input vector sequence
in Y with the same set of shared k-mers not included in X.)
For example, with three sequences S1, S2 and S3, if S1 and S2
share 20 k-mers not found in S3, these 20 k-mers would form
a single k-mer set with a pointer to the two source sequences
S1 and  S2. If additional k-mers are shared with all three
sequences S1, S2 and S3, these k-mers would form a separate
k-mer set with a pointer to all three sequences.
A candidate signature set is a k-mer set where k-mers in the
set are found in the vector data but not in the natural plasmid
or chromosomal DNA. Using k  = 20 as an example, the
1,625,171 signature candidates reduce to 7,270 signature sets,
each with at least 10 signatures from which representative
signatures can be chosen. Intuitively, shorter k-mers should
reduce the number of candidate signatures, but Figure 2
shows that the signature set size levels off at k = 50. This
means that longer signatures can be easily managed without
creating a signature candidate pool that is too large. The can-
didate signature set size is reduced further using a greedy
algorithm to iteratively select the k-mer set that maximally
Percentage of k-mers that are candidate signatures Figure 1
Percentage of k-mers that are candidate signatures. The red line plots the 
percentage of candidate vector signatures as a function of k (100% for a 
given k would mean all observed k-mers are signatures). The blue and 
green lines plot the percentage of artificial vector derived k-mers shared 
exclusively with natural plasmids and chromosomes, respectively.
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Signature sets. Plots of the number of k-mer sets containing signatures for 
k = 15 to 100.
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increases the number of sequences covered, reducing the size
to 364 (when k = 20).
Eleven complete sequence vectors were found to be without a
unique signature up to k = 47. For 9 of the 11 cases, the vector
sequence and the natural sequence are identical. At k = 23
and 47, a signature is found for the remaining two sequences.
Figure 3 shows a schematic of the overlap between the artifi-
cial vector sequence where the first signature appears at k =
23 and the natural plasmids with the two highest numbers of
shared nucleotides. (Note that, for clarity, matches to other
natural plasmid sequences are not shown.) The figure shows
maximal exact matches over 100 bases in length using MUM-
mer [18]. We found that 99.6% of the vector sequence maps
to the Escherichia coli plasmid with exact matches and 86%
matches exactly to the Erwinia amylovora plasmid. A signa-
ture first emerges at the multiple cloning site at position 614
(shown in Figure 3). Overall, the choice of k yields only mod-
erate changes in the signature set size and coverage. If micro-
arrays are used as the assay medium, the choice of probe
lengths can be tailored to fit a particular microarray design
[19].
The completely sequenced vectors were divided into five par-
titions to check how closely vectors excluded from the signa-
ture creation pipeline match the candidate signatures. The
hope is that a high percentage of the signatures are found in
unseen vectors while remaining distinct from the background
genomic sequence. The background genomic sequence is
defined here as all sequenced natural plasmids and all
sequenced bacterial and viral chromosomes along with the
assembled draft sequence. Each partition was searched
against a signature set generated from the remaining 80% of
the vector data using NCBI BLAST [20]. The background
genomic sequence was similarly searched against each of the
five signature sets. Each vector sequence and background
genomic sequence was assigned its average bit score from the
BLAST matches, plus the standard deviation. Support for dif-
ferentiating between the artificial vector sequence and a back-
ground sample via differential cross-hybridization is
enhanced when every artificial vector sequence's similarity to
Example artificial vector sequence mapped to two natural plasmids Figure 3
Example artificial vector sequence mapped to two natural plasmids. The vector sequence is shown in the middle (Phagemid cloning vector pTZ19R), which 
shares sequence with both the E. coli plasmid pCA4, and the Erwinia amylovora plasmid pEA2.8. Lines connecting the three sequences mark the beginning of 
exact matches between the artificial sequence and the two respective plasmids. The number next to each line is the length of exact match (for matches of 
100 or more bases). Functional annotation for the artificial vector sequence is given above the sequence (RS denotes recombination site). Position 614 
marks the starting point of the shortest signature found (k = 23). (Not drawn to scale.)
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the signature set is higher than the background genomic
sequence. It should be noted that the bit scores provide a
rough estimate of hybridization potential and additional
parameters may be used to optimize signature sets for a spe-
cific detection experiment and assay medium.
Two k-mer values, 30 and 60, were used with two signature
set sizes, a smaller and larger set averaging 28,414 and 77,184
k-mers, respectively. Values for k (30 and 60) were chosen to
examine signature types with different microarray hybridiza-
tion patterns using lengths that we know from experience
have different characteristics on our synthesized microarray
platform. An alternative BLAST approach called MCS-only
was included for comparison. MCS-only uses the multiple
cloning sites of vectors exclusively as the source for creating
signatures. The multiple cloning sites were first searched
against the background sequence using BLAST, and regions
without contiguous exact matches exceeding k were retained
as input for constructing candidate signatures.
The MCS-only approach has the advantage of being easier to
implement and requires less computational resources. Since
the multiple cloning sites are expected to be good identifiers
of vector sequence, it is possible that using all of the vector
sequence as input provides limited information for creating
signature data beyond what is already found at the multiple
cloning sites. There are, however, potential disadvantages to
this approach. Accessing the annotation specifying the multi-
ple cloning site in every vector sequence is not easy. Despite
our best efforts, we were unable to obtain multiple cloning
site annotations for 18% of the completely sequenced vectors,
although given the redundancy among vectors, the potential
for extracting a good signature set is still possible.
Figure 4 shows the percentage of background sequences with
bit scores below a given threshold (y-axis), versus the per-
centage of vector sequences with bit scores above the thresh-
old (x-axis). Discrimination performance is slightly higher for
the larger k-mer derived signature sets at most bit score
thresholds. The MCS-only signature sets (30-MCS-only and
60-MCS-only in Figure 4) show substantially reduced per-
formance compared with the more inclusive k-mer signature
set approach. One key limitation is that the MCS-only signa-
tures fail to correctly detect as many artificial vector
sequences. The best MCS-only performance, 60-MCS-only,
scored 98% of the artificial vector sequence above the back-
ground threshold but the threshold score had to be lowered to
a level where only 92% of the background sequence would be
rejected. The best k-mer derived signature set (60-large in
Figure 4) by contrast scored 99% of the artificial vectors
above the background threshold while rejecting 99.7% of the
background sequence. Although the percentage of vectors
detected and background sequence rejected is above 99%, a
small percentage of background sequence still matched well
with signatures. To reduce the potential for false positives,
signatures with sequences similar to the background were
removed. The resulting discrimination performance is shown
in Figure 5. The k-mer derived signature sets show improved
discrimination, with 100% of the background sequences scor-
ing below a fixed threshold, while close to 98% of the vector
sequence scored above the threshold. Thus, eliminating cer-
tain signatures reduced the potential for false positives while
raising the percentage of missed vectors by only 1%. The best
MCS-only signature set detection percentage (60-MCS-only
in Figure 5) drops to 92% without raising the background
sequence rejection percentage above 92%.
The results indicate that the limited annotation of multiple
cloning sites for vector sequences is not the only cause for the
drop in MCS-only performance. The signature-based
approach yields additional signatures outside the MCS region
that boost confidence in the prediction of a vector,
particularly in cases where the MCS region does not match
well with the signature set. An additional advantage of using
signatures outside the MCS region is to recover more infor-
mation about the detected vector. Since signatures can come
from other functional regions such as replication of origin
sites and selection marker genes, matches to these signatures
could provide additional information that would be useful in
learning more about a vector and host type embedded in a
complex sample.
Artificial vector sequence detection Figure 4
Artificial vector sequence detection. The percentage of correctly rejected 
background sequences (y-axis) versus correctly accepted artificial vector 
sequences (x-axis) using bit score thresholds. Each point is the percentage 
of background sequences (y-axis) with bit scores below a fixed bit score 
threshold versus the percentage of artificial vector sequences (x-axis) 
above the same bit score threshold. We examined 20 bit-score threshold 
values. Only the points with a rejection/acceptance percentage above 85% 
are shown. The six different signature sets are shown in the legend and are 
described by their k-mer size (30 and 60) and the signature set origin 
(large, small and MCS-only). The large and small sets are k-mer derived 
signature sets and MCS-only are signature sets derived exclusively from 
the multiple cloning site regions.http://genomebiology.com/2008/9/3/R56 Genome Biology 2008,     Volume 9, Issue 3, Article R56       Allen et al. R56.5
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It is important to note that longer probe lengths reduce
microarray hybridization specificity. Using shorter k-mer
sizes for microarray probe design may lead to more specific
detection rates compared with longer k-mers, since single
nucleotide differences are used to determine candidate signa-
tures for all values of k. The results in Figure 5 suggest that
longer probes can be filtered using BLAST to remove addi-
tional near matches to the background, which could improve
hybridization specificity while maintaining good coverage
across the complete set of artificial vectors.
Plasmid/vector conserved functional sequence
Figure 6 shows the percentage of candidate signature sets for
four select functional categories, coding sequence, multiple
cloning sites, unannotated regions and recombination sites,
for sets with at least 10 signatures and 10 k-mers. The highest
percentage of signature sets are multiple cloning sites, con-
firming that these regions are a good source of signatures, fol-
lowed by unannotated sequences. The functional category
with the smallest percentage of signatures is the recombina-
tion site. As one might expect, Figure 6 shows that those
regions subject to less-selective pressure yield higher num-
bers of candidate signatures; however, individual functional
categories yield over 60% of the signatures (CDS in Figure 6).
Although multiple cloning sites are an obvious choice for sig-
nature selection, in addition to limitations in access to func-
tional annotation, continued development of recombineering
methods [21], which use homologous recombination over
restriction enzymes, mean that signatures from a range of
functions should be included.
Figure 7 shows the percentage of k-mer sets shared between
vectors and natural plasmids but not with chromosomal
sequences, organized by functional category. Understanding
this distinction is important in determining where signatures
may confuse natural plasmids with artificial vector
sequences. Only 2.5 times as many k-mer sets are shared
exclusively with the chromosomal data for k = 23 compared
with sets shared exclusively with the natural plasmids,
despite there being roughly 60 times as much chromosomal
data. The origin of replication regions were found to be the
most common functional category shared exclusively among
natural plasmid and vector sequences while the multiple
cloning sites and primer sites are very rarely vector/plasmid
specific. Multiple cloning sites elements are most frequently
specific to the artificial vector sequence, but in cases when
they are not, they are found both in natural plasmids and
chromosomes.
With the availability of interactive software tools for vector
design [22], an automated procedure was developed to check
for additional signature candidates in natural plasmids. Plas-
mids were searched against the k-mer sets to find cases where
the sequence similarity to artificial vector sequence could
support attempts to convert natural plasmids to novel vectors
[23-26]. Including signatures with variations on the existing
vectors could serve to deter attempts to evade detection using
natural plasmids with small variations to known sequenced
vectors. The 20-mers for each natural plasmid were mapped
to the respective vector derived 20-mer sets; if the natural
plasmid contained 90% or more of the 20-mers in a set, the
natural plasmid was matched to the k-mer set. We found 21
natural plasmids from 10 bacteria and 5 non-species-specific
plasmids with at least 3,000 k-mers in at least three anno-
tated functional categories: coding sequence, replication ori-
gin and promoter, where k-mer sets have at least 50 k-mers.
Artificial vector sequence detection with a modified signature set Figure 5
Artificial vector sequence detection with a modified signature set. The 
percentage of correctly rejected background sequences (y-axis) versus 
correctly accepted artificial vector sequences (x-axis) using bit score 
thresholds after filtering out signatures with high bit score matches to the 
background sequence.
Signature set percentages for select functional annotation categories Figure 6
Signature set percentages for select functional annotation categories. 
Functional categories are protein coding genes (CDS), multiple cloning 
sites (MCS), no annotation and recombination sites.
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Table 1 lists the species names. Along with E. coli, other
potentially hazardous bacteria are present such as the
recently sequenced Yersinia pestis biovar Orientalis str.
IP275 plasmid [27]. Any one natural plasmid shared k-mer
set can be shared by tens or hundreds of vectors so vectors
with the largest common number of k-mer sets were found to
compare with previously used vectors, which could poten-
tially support the use of a new vector [28].
Y. pestis conserved 20-mer sets cluster into four distinct bac-
terial vector sets shown in Table 2. Each cluster specifies a
common vector (or vectors). For example, the largest cluster
labeled 1 in Table 2 contains kanamycin and streptomycin
drug-resistant genes along with recombination and transcrip-
tion termination sites, all mapping to two sequenced vectors
(accession numbers [GenBank:4262403, Gen-
Bank:4323404]). Table 3 describes vectors for the clusters in
Table 2. The common functional sequence between vectors
and newly sequenced natural plasmids suggests inclusion of a
supplemental set of natural plasmid-based signatures in
genetic engineering detection assays.
Conclusion
Candidate DNA signatures were found for nearly all artificial
vector sequence. In a small number of cases overlap between
natural plasmids and artificial vectors preclude detection
with DNA signatures. With two exceptions, where the signa-
tures were found at k = 23 and 47, the lack of signature cover-
age for a vector sequence was explained by the occurrence of
an equivalent natural analog, which makes clear the limits of
many vector/plasmid distinctions. Natural analogs must be
included in vector based signature detection systems along
with other natural plasmid derivatives, which could be used
to evade detection from the existing core signature set. With
the potential for plasmids to be converted into artificial vector
sequence [29,30], developing predictive DNA signatures is an
important challenge. At a minimum, signatures from the 21
plasmids sharing multiple functional elements with existing
artificial vector sequence should be included to track poten-
tially modified natural plasmids. Finding that 364 signatures
cover nearly the complete set of vector sequences means that
there is high sequence redundancy, making it feasible to
maintain an expanding database of DNA signatures to track
all sequenced vectors.
F u t u r e  w o r k  s h o u l d  b e  d i r e c t e d  t o w a r d s  b i o a s s a y  d e s i g n
using DNA signatures on microarrays to test the efficacy of
detecting genetically modified bacteria from a sample, which
includes both modified and naturally occurring bacteria. We
plan to collaborate more closely with scientists in the genetic
engineering field to refine our bioinformatics tools to
anticipate future natural plasmid-derived vector construc-
tion. As with any attempt to counter malicious use of technol-
ogy, detecting genetic engineering in microbes will be an
immense challenge that requires many different tools and
continual effort. Cooperating with the scientific community
to sequence and track available vector sequence will provide
an opportunity for DNA signatures to support detection and
deterrence against malicious genetic engineering
applications.
Materials and methods
Natural plasmid sequence was extracted from an Entrez
query of taxonomic classification 'other sequence; plasmids'
[31], GenBank plasmids and the Plasmid Database [32].
Sequences were checked for redundancy yielding the final
natural plasmid sequence total of 65,341,821 bases in 1,567
contigs. In the pre-processed form there is overlap between
Vector/plasmid shared k-mer sets for select functional annotation  categories Figure 7
Vector/plasmid shared k-mer sets for select functional annotation 
categories. Percentage of shared k-mer sets is shown for different k-mer 
sizes.
Table 1
Bacteria with plasmids matched to artificial vectors.
Enterococcus faecalis
Escherichia coli
Klebsiella pneumoniae
Photobacterium damselae subsp. Piscicida
Environmental samples uncultured bacterium
Pseudomonas aeruginosa
Salmonella enterica subsp. enterica serovar Typhi str. CT18
Salmonella typhimurium
Serratia marcescens
Staphylococcus aureus
Yersinia pestis biovar Orientalis str. IP275
Species with at least 3,000 20-mer matches to the vectors in three 
functional categories: protein coding gene, origin of replication region 
and promoter.
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the artificial vector set and the natural plasmid set. While
some plasmids are naturally occurring, they are also used in
genetic engineering. In cases where an engineered applica-
tion is found, the sequence was treated as an 'artificial vector
sequence'. The remaining artificial vector sequence was
downloaded from the GenBank vector set available via anon-
ymous ftp [33], ATCC [34], Virmatics [35] and an Entrez-
based query of sequences classified taxonomically as artificial
vector sequence. Vector sequences with fasta headers specify-
ing eukaryote cell targets were removed, along with duplicate
sequences. The background chromosomal sequence comes
from the KPATH [9] database, which contains all available
draft and completely sequenced microbial genomes (45,749
sequences totaling 4,057,440,823 bases).
Signature pipeline
Each vector sequence was assigned a unique integer identifier
starting from 0 to the total number of sequences minus 1. A
hash table was built with a hash key entry for each k-mer in
the vector sequence and the numeric identifiers stored in
order from the contributing sequences. An example sche-
matic of the hash table is labeled 'Hash table 1' in Figure 8. As
an example, the top entry in Figure 8 is k-mer-1 and is found
in five different sequences: 0, 5, 9, 12 and 100. The computa-
tional cost to build the hash table is the number of k-mers
(proportional to the total number of bases given as input)
times the cost of inserting a pointer to the originating
sequence for each k-mer into a sorted list, which is O(log s),
where s is the total number of sequences and reduces to a con-
stant value. This gives a linear runtime with respect to the
number of nucleotides given as input. If the total number of
input bases is n then there are O(n) bytes used for the keys
times 2 * s bytes (assuming 2 bytes per integer). In theory, up
to 3 TB of memory could be required, however, most k-mers
are found in a smaller subset of sequences, dramatically
reducing memory requirements. This problem can be viewed
in the context of other multiple whole genome exact seed
match comparison approaches that are potentially more
memory efficient using variants of suffix trees [36,37] minus
a step for chaining together conserved order blocks [16]. The
principal difference is the need for a sequence clustering step,
since k-mers are found in different subsets of the total set of
input sequences.
Once the initial hash table is built, the sequence pointers of
each k-mer entry become the keys for a second hash table,
which records every combination of vector sequence with
shared k-mers. A schematic of the hash table is labeled 'Hash
table 2' in Figure 8. As an example, the second key from the
top in Hash table 2 in Figure 8 forms a k-mer set called k-mer
set-2, which shows that three sequences, 5, 30 and 110, share
three k-mers, k-mer-2, k-mer-3 and k-mer-5. This compara-
tive sequence approach presents a linear runtime with respect
to the number of input nucleotides but has a theoretically
high memory cost (owing to an exponential number of possi-
ble cluster combinations). In practice the entire study
required less than 3 GB in online random access memory
(RAM). Google sparse hash tables [38] were used to limit
RAM consumption. DNA signatures are found by checking
each nucleotide in the background dataset (natural plasmids
Table 2
GenBank identifiers for vector sequence matching Y. pestis plasmid. 
Cluster k-mer sets Vector GenBank accession Functional elements
1 16 4262403, 4323404 Recombination site, CDS, promoter, transcription terminator
2 11 116119370, 984913 CDS, promoter, repeat region
3 2 120573441 Transcription terminator
4 2 Eight matching vectors Origin of Replication
Columns list a numeric identifier (Cluster), the number of k-mer sets in the cluster, GenBank identifiers (when two or less vectors match), and the 
conserved functional elements.
Table 3
Summary description from the GenBank annotation of vectors matched to the Y. pestis plasmid. 
GenBank 
accession
Host Purpose Comments
4262403 Broad range Cloning Gene cloning vectors for Rhodobacter sphaeroides
4323404 Broad range Cloning Gene cloning vectors for Rhodobacter sphaeroides
116119370 Unspecified Cloning The complete sequence of the BAC vector pECSBAC4
4984913 Escherichia coli Cloning Improved antibiotic-resistance gene cassettes and omega elements
120573441 Broad range Expression Analysis of transformation in Acinetobacter baylyi
Describes the vectors listed in Table 2.Genome Biology 2008, 9:R56
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and chromosomal sequence) and storing the k-mers shared
with the initial vector derived hash table.
The background and vector sequences were searched against
the signature set so that comparable sized query database
sizes were used in the comparison. The background genomic
sequence was searched against all five signature sets and the
average result was taken. Default parameter values were used
for BLAST. The second plot (Figure 5) shows signatures
removed from the detection set using a bit score threshold of
100 and 50 for k = 60 and 30, respectively. A signature was
removed if it has at least one match with bit score above the
threshold. The two k-mer based signature set sizes were cho-
sen from two different criteria. The larger set was taken by
selecting the first 10 signatures from each k-mer set (chosen
at random). The smaller set was chosen by taking a maximum
of the first 10 signatures per vector sequence selecting signa-
tures shared by the largest number of vectors.
Matching vectors with plasmids
The vector sequences with the greatest number of k-mer sets
shared with a natural plasmid of interest (such as the Y. pestis
plasmid given as an example) were found using a graph
theoretic approach. Each k-mer set is a node in a graph, with
labeled edges between two nodes listing the vectors in
common. An example is shown in Figure 8. In general, if k-mer
set A and k-mer set B are two nodes in the graph, node A con-
tains the k-mers shared by the vectors 
and node B  contains the k-mers shared by the vectors
. An edge between A and B exists if the
intersection between VA and VB is non-empty and the edge is
labeled with the names of the shared vectors. For example, in
Figure 8 there is an edge between k-mer set 1 and k-mer set 4
labeled with their common vectors 5 and 9. Finding the k-mer
sets with the greatest number of common vectors finds the
maximal clique in the graph [39] with the added constraint
that every edge in the clique must share at least one vector in
common with every other edge in the clique. Once the maxi-
mal clique with edge label constraints is found, it is removed
from the graph and the process is repeated for the remaining
k-mer sets until all nodes (k-mer sets) are assigned to a max-
imal clique. The cluster labeled 1 in Table 2 is shown in graph
form in Figure 9; for clarity the edge labels are not shown, but
each edge is labeled with the two common matching vectors:
[GenBank:4262403] and [GenBank:4323404].
List of abbreviations
CDS, coding sequence; MCS, multiple cloning site; PCR,
polymerase chain reaction, RAM, random access memory.
Hash tables and k-mer set clusters Figure 8
Hash tables and k-mer set clusters. The left panel shows schematic of an example hash table (Hash table 1). Each key is a k-mer (k-mer-1, k-mer-2,..., k-
mer-7) with an entry storing a list of numeric identifiers for the sequences with the k-mer substring. The upper right panel shows the second hash table 
(Hash table 2), where each key is the set of k-mers common among the set of vectors specified by the key. The bottom right panel shows the graph 
representation of the four k-mer sets (numbered 1 to 4) with k-mer sets as nodes and labeled edges between nodes representing shared vectors between 
nodes.
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Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is the list of artifi-
cial vector identifiers. Additional data file 2 is the list of natu-
ral plasmid identifiers. Additional data file 3 is the complete
set of 30-mer signatures used in the cross-validation set.
k-mer set cluster Figure 9
k-mer set cluster. Graph of cluster 1 from Table 2. Each node shows the number of k-mers in the set (left number), the number of artificial vectors sharing 
the k-mer substrings (right number) and the functional annotation. Edges denote common vectors between two nodes. Abbreviations are as follows: 
DHPS, dihydropteroate synthase; STRA, streptomycin resistance; Kanamycin/Neomycin, Kanamycin/Neomycin resistance; Recombsite, recombination 
site; Transterm, transcription termination.Genome Biology 2008, 9:R56
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Additional data file 4 is the complete set of 60-mer signatures
used in the cross-validation set.
Additional data file 1 The list of artificial vector identifiers The list of artificial vector identifiers. Click here for additional data file Additional data file 2 The list of natural plasmid identifiers The list of natural plasmid identifiers Click here for additional data file Additional data file 3 The complete set of 30-mer signatures used in the cross-validation  set The complete set of 30-mer signatures used in the cross-validation  set Click here for additional data file Additional data file 4 The complete set of 60-mer signatures used in the cross-validation  set The complete set of 60-mer signatures used in the cross-validation  set Click here for additional data file
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